A systematic review of the role of human papillomavirus testing within a cervical screening programme.

A systematic review of the role of human papillomavirus testing within a cervical screening programme.

Bibliographic Details
Main Authors:	Cuzick, Sasieni, Davies, Adams, Normand, Frater, van Ballegooijen, van den Akker
Format:	Article
Language:	English
Published:	NIHR Journals Library 1999-01-01
Series:	Health Technology Assessment
Online Access:	https://doi.org/10.3310/hta3140

Similar Items

Cervical screening at age 50-64 years and the risk of cervical cancer at age 65 years and older: population-based case control study.
by: Alejandra Castañón, et al.
Published: (2014-01-01)

Utility of Human Papillomavirus Testing for Cervical Cancer Screening in Korea
by: Mee-seon Kim, et al.
Published: (2020-03-01)

Self-Sampling for Human Papillomavirus Testing among Non-Attenders Increases Attendance to the Norwegian Cervical Cancer Screening Programme.
by: Espen Enerly, et al.
Published: (2016-01-01)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening.
by: Karin Sundström, et al.
Published: (2021-01-01)

Need for expanded HPV genotyping for cervical screening
by: Jack Cuzick, et al.
Published: (2016-12-01)

Evaluation of human-papillomavirus testing and visual inspection for cervical cancer screening in Rwanda
by: M. Chantal Umulisa, et al.
Published: (2018-04-01)

Real-world effectiveness of primary screening with high-risk human papillomavirus testing in the cervical cancer screening programme in China: a nationwide, population-based study
by: Yanxia Zhao, et al.
Published: (2021-07-01)

Human papillomavirus testing to identify older women who could be safely withdrawn from cervical screening : a retrospective investigation using archived smears from the NHS Cervical Screening Programme
by: Grainge, Matthew
Published: (2004)

Human Papillomavirus DNA testing with cytology triage in cervical screening: Influence of revealed versus concealed Human Papillomavirus Status
by: Richardson, Lyndsay
Published: (2011)

ARTISTIC: a randomised trial of human papillomavirus (HPV) testing in primary cervical screening
by: HC Kitchener, et al.
Published: (2009-11-01)

Cervical Human Papillomavirus Screening among Older Women
by: Matthew J. Grainge, et al.
Published: (2005-11-01)

Correlates of women’s intentions to be screened for human papillomavirus for cervical cancer screening with an extended interval
by: Gina S. Ogilvie, et al.
Published: (2016-03-01)

Xpert human papillomavirus test is a promising cervical cancer screening test for HIV-seropositive women
by: Zizipho Z.A. Mbulawa, et al.
Published: (2016-12-01)

Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs
by: Sarah Gupta, et al.
Published: (2018-04-01)

Adding a quadrivalent human papillomavirus vaccine to the UK cervical cancer screening programme: A cost-effectiveness analysis
by: Barnabas Ruanne V, et al.
Published: (2008-02-01)

Qualitative Evidence Synthesis on Self-Collection for Human Papillomavirus–Based Cervical Screening: Protocol for Systematic Review
by: Camara, Hawa, et al.
Published: (2020-10-01)

Cost‐effectiveness analysis of primary human papillomavirus testing in cervical cancer screening: Results from the HPV FOCAL Trial
by: Ian Cromwell, et al.
Published: (2021-05-01)

Visual inspection after acetic acid (VIA) is highly heterogeneous in primary cervical screening in Amazonian Peru.
by: Maribel Almonte, et al.
Published: (2015-01-01)

Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
by: Naryshkin S, et al.
Published: (2012-11-01)

Limitations of widely used high-risk human papillomavirus laboratory-developed testing in cervical cancer screening
by: Nance KV
Published: (2013-01-01)

Cost-Effectiveness Analysis of Cervical Cancer Screening with Pap Smear and Human Papillomavirus DNA Testing in Taiwan
by: Ines Hang-Iao Chow, et al.
Published: (2008)

The evaluation of cervical cancer screening programmes
by: Parkin, Donald Maxwell
Published: (1984)

Clinical validation of REALQUALITY RQ-HPV Screen according to the international guidelines for human papillomavirus DNA test requirements for cervical screening
by: Michela Iacobellis, et al.
Published: (2018-03-01)

Human papillomavirus types distribution in organised cervical cancer screening in France.
by: Isabelle Heard, et al.
Published: (2013-01-01)

Evaluation of human-papillomavirus screening for cervical cancer in China’s rural population
by: Ling Li, et al.
Published: (2019-12-01)

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study.
by: Suzette M Matthijsse, et al.
Published: (2018-01-01)

Clinical validation of the HPVIR high-risk HPV test on cervical samples according to the international guidelines for human papillomavirus DNA test requirements for cervical cancer screening
by: Inger Gustavsson, et al.
Published: (2019-08-01)

Cost-Effectiveness Analysis of Cervical Cancer Screening Supplemented with Self-Sampling for Human Papillomavirus DNA Testing in Taiwan
by: Ping-Ching Tsai, et al.
Published: (2012)

Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
by: Laura Reques, et al.
Published: (2021-05-01)

Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: the ESTAMPA screening study protocol
by: Nathalie Broutet, et al.
Published: (2020-05-01)

Understanding Men’s Perceptions of Human Papillomavirus and Cervical Cancer Screening in Kampala, Uganda
by: Erin Moses, et al.
Published: (2018-02-01)

The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China
by: Wang Shizhuo, et al.
Published: (2012-05-01)

Modeling human papillomavirus and cervical cancer in the United States for analyses of screening and vaccination
by: Ortendahl Jesse, et al.
Published: (2007-10-01)

Frequency of Human papillomavirus in women attending cervical cancer screening program in Chile
by: Priscilla Brebi, et al.
Published: (2017-08-01)

Evaluation of the national cervical screening programme in Chile
by: Scalabrino, Ana Pereira
Published: (2011)

Lectins in Cervical Screening
by: Anita WW Lim, et al.
Published: (2020-07-01)

Age patterns of human papillomavirus infection as primary screening test for cervical cancer and subsequent triage with visual inspection in Honduras
by: Manuel Sandoval, et al.
Published: (2020-08-01)

Factors influencing cervical cancer screening programme implementation within private health care sectors in Soshanguve
by: Mookeng, Mampete Jemina
Published: (2009)

Factors influencing cervical cancer screening programme implementation within private health care sectors in Soshanguve
by: Mookeng, Mampete Jemina
Published: (2009)

Human Papillomavirus and Cervical Cancer
by: Elizabeth R. Unger, et al.
Published: (2004-11-01)